Multi-award winning medical device manufacturer attends Arab Health, Dubai for 8th year in a row

SHEIKH ZAYED RD, UAE - Jan. 2, 2018 - PRLog -- Established in 1976, Bedfont are a second-generation family company that has specialised in the design and manufacture of exhaled breath and gas monitoring instruments for medical, scientific and industrial markets globally, for over 40 years. For the 8^th year is a row, Bedfont are returning to Arab Health, Dubai, to showcase their high quality breath analysis medical devices, in their ambition to continue innovating and improving health worldwide.

Bedfont's Medi-Gas Check range of medical pipeline testing equipment safeguards patients and staff against harmful gases. By testing the gas in the pipeline, its quantity and quality can be verified to ensure no harmful gas leaking, but also that the right gas is administered to patients. Their breath analysers include carbon monoxide (CO) monitors such as the Smokerlyzer®, used for smoking cessation, and the ToxCO®, used by emergency services to diagnose CO poisoning. The NObreath® FeNO monitor provides accurate analysis of airway inflammation for improving asthma management, and the Gastrolyzer® range aids in the detection of gastrointestinal disorders and food intolerances. Quick and non-invasive, breath analysis is the new blood test.

Andy Smith, Sales Manager, says, "2018 marks the 8^th year in a row that Bedfont® has attended the Arab Health exhibition and each year has been central to our growth in the Middle Eastern markets. One example would be our new Middle East Territory Manager, Ahmed Gamil. We met Ahmed at Arab Health and have worked alongside him as our distributor. The longevity of our relationship has been promising for our presence in the Middle East and so last year we employed Ahmed to help us grow further."

To see Bedfont and their full range of products, please visit their stand H7E15.

https://www.bedfont.com